Biomarker positivity among breast cancer patients as of 2017

Published by
Matej Mikulic,
Jan 22, 2020
This statistic depicts the incidence of biomarker positivity among patients with breast cancer, as of 2017. According to the data, 53 percent of patients with HER2-HR+, postmenopausal breast cancer had positive biomarker results.

Percentage of U.S. patients with breast cancer that tested positive for select biomarkers as of 2017

Loading statistic...

© Statista 2023
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

May 2018

Region

Worldwide

Survey time period

as of 2017

Supplementary notes

* Biomarker newly available post-2006

Citation formats
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$229 USD $199 USD / Month *
in the first 12 months
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Other statistics that may interest you

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Statistics on

About the industry

10

About the region

10

Selected statistics

6

Other regions

10

Related statistics

10

Further related statistics

10

Further Content: You might find this interesting as well

Statistics

Topics

Cancer in RussiaPharmaceutical industry in RussiaAlcohol and healthGlobal healthHealth and wellness food trends in Europe
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Learn more about how Statista can support your business.
Menu